Century Therapeutics, Inc. (IPSC) Stock Overview
Explore Century Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Century Therapeutics, Inc. (IPSC)
Key Financials
Key Financials
Market Cap
180.9M
P/E Ratio
-1.68
EPS (TTM)
$-1.06
ROE
-0.53%
IPSC Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Century Therapeutics, Inc. (NASDAQ: IPSC) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Century Therapeutics, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of IPSC on the NASDAQ shows an RSI of 41.16, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $2.42 for the NASDAQ listing.
Key metrics behind Century Therapeutics, Inc.'s NASDAQ-traded stock include a P/E ratio of -1.68 and a market capitalization of 180.9M. Combined with our AI analysis, these give both institutional and retail investors a clear view of IPSC on the NASDAQ.